Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 4:08 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 3049–3072 of 7,489 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Control Clear all

Conditions: Breast Cancer, Malignant Neoplasm of Breast
Interventions: Immediate Breast Reconstruction, Delayed Breast Reconstruction, Breast-Q questionnaire; Procedure · Other
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 19 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Rhinitis, Allergic, Seasonal
Interventions: PQ Grass, Active Placebo, Standard Placebo; Biological · Drug
Lead sponsor: Allergy Therapeutics; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 8
States / cities: Lexington, Kentucky • White Marsh, Maryland • Ocean Township, New Jersey + 5 more

Conditions: Chronic Kidney Disease and Hypertension
Interventions: Baxdrostat/dapagliflozin, Placebo/dapagliflozin; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years and older
Enrollment: 5,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 133
States / cities: Fairhope, Alabama • Sun City, Arizona • Tucson, Arizona + 117 more

Conditions: Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases
Interventions: TransCon PTH, Placebo for TransCon PTH; Combination Product
Lead sponsor: Ascendis Pharma A/S; Industry
Eligibility: 18 Years and older
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 5
States / cities: Chicago, Illinois • Rochester, Minnesota • Great Neck, New York + 2 more

Conditions: Heart Failure
Interventions: Standard configuration vs. azygos coil; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Fatigue
Interventions: Mandatory Naps; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Not listed
Enrollment: 352 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Diabetic Foot Infection
Interventions: Topical pexiganan cream 0.8%, Topical placebo cream, Standard wound care; Drug · Other
Lead sponsor: Dipexium Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 39
States / cities: Phoenix, Arizona • Tucson, Arizona • Jonesboro, Arkansas + 36 more

Conditions: Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Interventions: Avacopan, Placebo, Standard of Care; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2036
U.S. locations: 62
States / cities: Anchorage, Alaska • Scottsdale, Arizona • Surprise, Arizona + 57 more

Conditions: Physical Therapy
Interventions: STABL Virtual Rehabilitation; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Basilar Thumb Arthritis
Interventions: Suture Tape Reconstruction; Device
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Prostate Cancer
Interventions: MyProstateScore 2.0 Results; Other
Lead sponsor: Qure Healthcare, LLC; Industry
Eligibility: Not listed
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Rheumatoid Arthritis
Interventions: GP2013, MabThera, Rituxan; Biological
Lead sponsor: Sandoz; Industry
Eligibility: 18 Years and older
Enrollment: 312 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 16
States / cities: Los Angeles, California • Lexington, Kentucky • Cumberland, Maryland + 13 more

Conditions: Gastroesophageal Reflux Disease (GERD)
Interventions: EsophyX System with SerosaFuse fasteners, PPI; Device · Drug
Lead sponsor: EndoGastric Solutions; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Redmond, Washington

Conditions: Tobacco-Related Carcinoma
Interventions: Best Practice, Smoking Cessation Intervention, Survey Administration; Other · Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 575 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Muscle Weakness, Pain, Postoperative, Paresthesia, Pain, Muscle
Interventions: Depo-Medrol, Gel-Flow NT; Drug
Lead sponsor: Hardeep Singh; Other
Eligibility: 18 Years to 75 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Premature Infant, Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse), Development, Child, Parent-Child Relations
Interventions: Cognitive Behavioral Therapy; Behavioral
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: Not listed
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Hyperkalemia
Interventions: Patiromer Powder for Oral Suspension [Veltassa], Placebo; Drug
Lead sponsor: Comprehensive Research Associates; Industry
Eligibility: 18 Years and older
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 19
States / cities: Stanford, California • New Haven, Connecticut • Newark, Delaware + 13 more

Conditions: Open Abdomen
Interventions: AbCLO (Abdominal Wall Closure) Device; Device
Lead sponsor: Tufts Medical Center; Other
Eligibility: 18 Years to 100 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Los Angeles, California • Boston, Massachusetts

Conditions: Relapse/Recurrence, Substance Use (Drugs, Alcohol), Burnout
Interventions: Mindfulness Based Relapse Prevention, Standard of Care; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 100 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Immunization
Interventions: Music Therapy; Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 48 Months to 72 Months
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 3
States / cities: Tallahassee, Florida • Bainbridge, Georgia

Conditions: Wounds and Injury
Interventions: Recell, Control; Device · Procedure
Lead sponsor: Rubin, J. Peter, MD; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Polymyositis, Dermatomyositis
Interventions: Anifrolumab (blinded), Placebo, Anifrolumab (unblinded, open label); Combination Product · Other
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 43
States / cities: Phoenix, Arizona • Irvine, California • Aurora, Colorado + 38 more

Conditions: COPD
Interventions: Curcumin therapy, Placebo, Standard care; Dietary Supplement · Other
Lead sponsor: Danbury Hospital; Other
Eligibility: 40 Years to 89 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Danbury, Connecticut

Conditions: Joint Pain, Trouble Balancing
Interventions: Evenup; Device
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years to 64 Years
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

Breast Reconstruction Following Breast Cancer in Very High Risk Patients

An Exploratory Study of PQ Grass 27600 SU

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism

The Effect of an Azygos Vein Coil on Defibrillation Threshold

A Randomized Controlled Trial of Mandatory Naps for Physicians in Training

Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

Efficacy of STABL Virtual Rehabilitation

Trapeziectomy: Internal Brace vs. Ligament Reconstruction (Prospective)

Clinical Utility of MyProstateScore 2.0 P2

GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard Therapy

The EndoGastric Solutions TEMPO Trial

A Smoke-Free Home Intervention in Tribal Communities

Depo-Medrol on Psoas After LLIF

Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)

Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management

Assessment of a Non-invasive Device in the Management of Open Abdomen (AbCLO)

Mindfulness-based Relapse Prevention for Peer Workers

Music Therapy as Procedural Support for Young Children Undergoing Immunizations

Epidermal Coverage of Traumatic Wound Injuries Via Use of Autologous Spray Skin Applied Over Bilayered Wound Matrix

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

Curcumin in Management of Chronic Obstructive Pulmonary Disease

Study of an Orthotic Designed to Equalize Leg Lengths for Patients With Injuries Managed in Walking Boots